Source Feed: The Globe and Mail
Author: Sierra Bein
Publication Date: October 6, 2025 - 13:42
Globe Climate: Lessons from wildfire survivors
October 6, 2025
If you’re reading this on the web or someone forwarded this e-mail newsletter to you, you can sign up for Globe Climate and all Globe newsletters here.
Good afternoon, and welcome to Globe Climate, a newsletter about climate change, environment and resources in Canada.
Lecanemab is the first new treatment for Alzheimer’s disease to reach Canada in 20 years, and Health Canada’s recent authorization of the disease-modifying drug has understandably triggered hope and excitement.But for some researchers and clinicians who treat the disease, the development also represents a complicated story – one where enthusiasm for a new and desperately needed drug is tempered by sobering realities around its efficacy, accessibility and impact on an already strained health care system.
October 28, 2025 - 07:00 | Jennifer Yang | The Globe and Mail
Patience is a virtue but it didn't pay off for the Toronto Blue Jays fans who stuck it out until almost 3 a.m. at Rogers Centre for a watch party.
October 28, 2025 - 06:37 | Globalnews Digital | Global News - Ottawa
In 2023, a new meme began spreading among authors on Instagram. A screenshot of a search box holds an author’s name; below it, there’s a list of book titles. The author is relaying that each displayed title has been used without permission by a tech company to teach a large language model—or LLM—to speak and think. The captions contain expletives, or paragraphs about corporate greed, or AI’s exorbitant water use.
The first wave of these posts came in September of that year. The Atlantic scrutinized an AI training data set called Books3, composed of “large, unlabeled blocks of text” and...
October 28, 2025 - 06:31 | Thea Lim | Walrus

Comments
Be the first to comment